Eli Lilly declares $1.73 dividend per share for Q2 2026, payable June 10.

Eli Lilly's board announced a $1.73 dividend per share for the second quarter of 2026, payable on June 10 to shareholders recorded by May 15. This dividend reflects the company's ongoing commitment to returning value to shareholders amid its continued advancements in biotechnology and medicine. Investors can expect this payout as part of Lilly's strategy to support its growth and innovation in treating major health challenges globally.